Pharmaceutical Industry discussion, review, analysis, news and information. |
|
Jan25
|
 MAP Pharmaceuticals secured $25.25 million in funding. Proceeds from its Series C financing will be used primarily to advance the Phase II clinical development of the company's two lead drug candidates for the treatment of asthma and migraine. PreferredTime received $3 Million in new financing to be used to advance the sales and marketing of its pharmaceutical rep visit coordination service that was launched nationally in May 2005. |
|
Jan25
|
Do you love to read about this topic? Do you have an expertise or a passion in this topic? Love to write? Want to make money writing? We are Know More Media, a rapidly growing network of business-related blogs, and...
Continue Reading
|
|
Jan23
|
PharmaGazette provides news and information specifically for the pharmaceutical industry. We will discuss the latest news, information and research on the business and government agencies that develop, approve and distribute pharmaceutical products.On a daily basis, PharmaGazette will offer insightful analysis...
Continue Reading
|
Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!
BIZZlogos - Add your logo - free link to your site| View Network Map Network Feed List (OPML) Know More Media Network Feed |
PharmaGazette is a member of the Know More Media network of business related blogs.
Here are some current headlines from some of our business publications:
ProductivityGoal | CallCenterScript |
AdHurl | TheBizofKnowledge |
LandingTheDeal | CustomersAreAlways |
HealthCareVox | BrainBasedBusiness |
TheInsurancePolicy | MarketingBlurb |
Write for us About us Contact Advertise Privacy Disclaimer
This weblog is licensed under a Creative Commons License.
